Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi‐arm phase Ib study | Zendy

AI Assistant Blog Pricing

Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi‐arm phase Ib study

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.